BMY vs NUKKW · P/E 17, rev $24.46B vs $1.21B cap
Bristol-Myers Squibb Company (BMY) versus Nukkleus Inc (NUKKW) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Nukkleus Inc (NUKKW) is a software - application company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
NUKKW does not have a complete income-statement cache yet.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. NUKKW currently screens at market cap $1.21B.
Not investment advice. Open the BMY and NUKKW stock pages for the full models.
Not investment advice.